Cynthia E. Dunbar

Cynthia Dunbar is an American scientist and hematologist at the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH). She is the Branch Chief of the Translational Stem Cell Biology Branch.

She was the Editor-in-Chief of Blood, the flagship publication of the American Society of Hematology (ASH), from 2007 to 2012. She is currently (2025) Vice-President of ASH and will become President in 2027. In 2020, she was elected to the National Academy of Medicine for "leading pioneering genetic marking and therapy trials targeting hematopoietic stem cells, and developing uniquely predictive non-human primate models to successfully improve the safety and efficiency of various gene therapies as well as gain insights into hematopoiesis and immunology".